{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/biohaven-reports-first-in-human-dosing-of-oral-pkm2-modulator-bhv-8100-targeting-metabolic-restoration-and-immunomodulation-302786647.html", "message": "News view counter 769635 successfully enlarged"}